Last checked at 21 Apr 2010 15:41
Craneware plc
("Craneware" or the "Company")
Directors Shareholding
21 April 2010 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, has been informed that two Directors in the Company have today made the following transactions in ordinary shares of 1p each in the Company ("Ordinary Shares"):
| Name | No. of Ordinary Shares sold | Price | No. of Ordinary Shares post sale | % held post sale |
| Keith Neilson (Chief Executive Officer) | 489,756 | 410p | 3,398,044 | 13.4% |
| Neil Heywood (Non-Executive Director) | 7,346 | 410p | 127,926 | 0.5% |
Keith Neilson remains the largest shareholder in the Company.
In addition, Gordon Craig (Chief Technology Officer), who is not a Director of the Company, has today sold 244,878 Ordinary Shares at a price 410p per share. Following this transaction, Mr. Craig has a total holding in the Company of 244,878 Ordinary Shares which represents 12.4% of the total issued share capital.
For further information, please contact:
| Craneware plc | KBC Peel Hunt | ICIS |
| +44 (0)1506 407 666 | +44 (0)20 7418 8900 | +44 (0)20 7651 8688 |
| Keith Neilson, CEO | Jonathan Marren | Caroline Evans-Jones |
| Craig Preston, CFO | Richard Kauffer | Fiona Conroy |
|
| Dan Webster |
|
About Craneware
Founded in 1999, Craneware has headquarters in Livingston, Scotland with offices in Florida, Arizona and Kansas, employing over 130 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.